Moleculin Biotech, Inc. (MBRX)
7.90
-0.82
(-9.40%)
USD |
NASDAQ |
Oct 30, 16:00
8.10
+0.20
(+2.53%)
After-Hours: 20:00
Moleculin Biotech Market Cap : 2.804M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.804M |
| October 29, 2026 | 3.096M |
| October 28, 2026 | 3.104M |
| October 27, 2026 | 3.289M |
| October 26, 2026 | 2.515M |
| October 23, 2026 | 2.308M |
| October 22, 2026 | 2.091M |
| October 21, 2026 | 2.24M |
| October 20, 2026 | 2.197M |
| October 19, 2026 | 1.882M |
| October 16, 2026 | 1.991M |
| October 15, 2026 | 2.628M |
| October 14, 2026 | 58.36M |
| October 13, 2026 | 61.80M |
| October 12, 2026 | 58.77M |
| October 09, 2026 | 62.76M |
| October 08, 2026 | 60.21M |
| October 07, 2026 | 62.32M |
| October 06, 2026 | 63.26M |
| October 05, 2026 | 67.68M |
| October 02, 2026 | 69.13M |
| October 01, 2026 | 71.54M |
| September 30, 2026 | 71.06M |
| September 29, 2026 | 74.75M |
| September 28, 2026 | 80.80M |
| Date | Value |
|---|---|
| September 25, 2026 | 85.43M |
| September 24, 2026 | 80.50M |
| September 23, 2026 | 74.96M |
| September 22, 2026 | 80.23M |
| September 21, 2026 | 73.87M |
| September 18, 2026 | 109.78M |
| September 17, 2026 | 110.76M |
| September 16, 2026 | 105.08M |
| September 15, 2026 | 106.73M |
| September 14, 2026 | 110.08M |
| September 11, 2026 | 101.53M |
| September 10, 2026 | 117.85M |
| September 09, 2026 | 108.63M |
| September 08, 2026 | 106.51M |
| September 04, 2026 | 100.81M |
| September 03, 2026 | 95.92M |
| September 02, 2026 | 98.55M |
| September 01, 2026 | 92.30M |
| August 31, 2026 | 91.55M |
| August 28, 2026 | 92.29M |
| August 27, 2026 | 97.80M |
| August 26, 2026 | 85.20M |
| August 25, 2026 | 86.76M |
| August 24, 2026 | 86.52M |
| August 21, 2026 | 84.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.544B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 280.37M |
| Savara, Inc. | 990.03M |
| Vericel Corp. | 2.060B |
Market Cap Related Metrics
| Price to Book Value | 0.242 |
| Price | 7.90 |
| Earnings Yield | -4.34K% |